In this study, we evaluated a commonly used dengue RDT (SD BIOLINE Dengue IgG/IgM) and report for the first time the evaluation of new dengue and Zika RDTs developed by Excivion, which use a modified E antigen to distinguish previous DENV and ZIKV immunity. Here, CD40LG is linked to dengue disease.